Publication - Statistics
Scottish Health Survey 2018: main report - revised 2020
An amended version of the Scottish Health Survey 2018 main report.
Table 4.5: Use of NRT and other products, 2018, by age and sex
Base: Aged 16 and over ex-smokers or ever attempted to stop smoking | 2018 | ||||||||
---|---|---|---|---|---|---|---|---|---|
NRT use | Age | Total | |||||||
16-24 | 25-34 | 35-44 | 45-54 | 55-64 | 65-74 | 75+ | |||
% | % | % | % | % | % | % | % | ||
Men | Nicotine gum, nicotine patches, nasal spray/nicotine inhaler or lozenge/microtab | [10] | 18 | 33 | 34 | 25 | 31 | 11 | 26 |
Champix/Valenicline or Zyban/Bupropian | [-] | 2 | 2 | 10 | 7 | 6 | - | 5 | |
Electronic cigarette/vaping device | [32] | 31 | 17 | 19 | 22 | 7 | 5 | 19 | |
Not used any of the above | [65] | 62 | 57 | 48 | 58 | 64 | 89 | 61 | |
Women | Nicotine gum, nicotine patches, nasal spray/nicotine inhaler or lozenge/microtab | [15] | 30 | 27 | 36 | 31 | 24 | 25 | 29 |
Champix/Valenicline or Zyban/Bupropian | [-] | 3 | 6 | 9 | 6 | 3 | - | 5 | |
Electronic cigarette/vaping device | [32] | 17 | 26 | 22 | 13 | 12 | 6 | 18 | |
Not used any of the above | [60] | 58 | 53 | 48 | 58 | 65 | 72 | 58 | |
All adults | Nicotine gum, nicotine patches, nasal spray/nicotine inhaler or lozenge/microtab | 12 | 24 | 30 | 35 | 28 | 28 | 18 | 27 |
Champix/Valenicline or Zyban/Bupropian | - | 3 | 4 | 10 | 6 | 5 | - | 5 | |
Electronic cigarette/vaping device | 32 | 24 | 22 | 20 | 18 | 9 | 5 | 18 | |
Not used any of the above | 62 | 60 | 55 | 48 | 58 | 65 | 80 | 59 | |
Unweighted bases | Men | 23 | 100 | 102 | 143 | 154 | 157 | 116 | 795 |
Women | 39 | 144 | 162 | 197 | 192 | 191 | 105 | 1030 | |
All adults | 62 | 244 | 264 | 340 | 346 | 348 | 221 | 1825 | |
Weighted bases | Men | 43 | 163 | 122 | 163 | 149 | 114 | 81 | 834 |
Women | 46 | 150 | 141 | 184 | 150 | 132 | 89 | 893 | |
All adults | 89 | 313 | 263 | 347 | 299 | 247 | 170 | 1727 |
Square brackets around numbers denote that interpretation of the data should be cautious due to low bases for these sub-groups
Contact
There is a problem
Thanks for your feedback